Over the past 50 years, the treatment of young patients with acute lymphoblastic leukemia (ALL) has significantly improved, and is one of the success stories of cancer treatment. This success is measured by the improved survival of childhood ALL patients from less than 10% in the 1960s to more than
No takes yet. Share an insight, caveat, or question.
Jan Cools (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: